MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

New Mechanism for the Reimbursement of Skin Substitutes Aimed at Curbing Fraud, Waste and AbuseMARIETTA, Ga., July 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”) proposal. “We welcome and support improvements to Medicare’s reimbursement of skin substitutes across all care settings. The proposed rule, which was published yesterday afternoo ...